Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age

British Journal of Anaesthesia

Volumn 100, Issue 5, 2008, Pages 697-700

  Vilo, S ^a   Rautiainen, P ^b   Kaisti, K ^a   Aantaa, R ^a   Scheinin, M ^c   Manner, T ^a   Olkkola, K T ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Children; Pharmacokinetics, dexmedetomidine; Sedation

Indexed keywords

DEXMEDETOMIDINE; MIDAZOLAM; THIOPENTAL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT;

ABSENCE OF SIDE EFFECTS; ARTICLE; BRONCHOSCOPY; CALCULATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; ELECTIVE SURGERY; FEMALE; HUMAN; INFANT; MALE; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STEADY STATE; AGING; BLOOD; CONSCIOUS SEDATION; DRUG SCREENING; HALF LIFE TIME; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NEWBORN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESCHOOL CHILD;

ADRENERGIC ALPHA-AGONISTS; AGING; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; CONSCIOUS SEDATION; DEXMEDETOMIDINE; DRUG EVALUATION; FEMALE; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 43249090099     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen070     Document Type: Article

References (20)

1. Hsu YW, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics: Part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101: 1066
2. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98: 428
3. Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002; 12: 171-5
4. Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J 2003; 96: 871-5
5. Tobias JD, Berkenbosch JW. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004; 97: 451-5
6. Nichols DP, Berkenbosch JW, Tobias JD. Rescue sedation with dexmedetomidine for diagnostic imaging: a preliminary report. Paediatr Anaesth 2005; 15: 199-203
7. Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005; 94: 821-4
8. Hammer GB, Philip BM, Schroeder AR, Rosen FS, Koltai PJ. Prolonged infusion of dexmedetomidine for sedation following tracheal resection. Paediatr Anaesth 2005; 15: 616-20
9. Walker J, Maccallum M, Fischer C, Kopcha R, Saylors R, McCall J. Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006; 27: 206-10
10. Chrysostomou C, Di Filippo S, Manrique A-M, et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 2006; 7: 126-87
11. European Medicines Agency. ICH topic E11, Clinical investigation of medicinal products in the paediatric population. Note for guidance on clinical investigation of medicinal products in the paediatric population. 2001
12. Snapir A, Posti J, Kentala E, et al. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology 2006; 105: 902-10
13. Akaike H. An information criterion (AIC). Math Sci 1976; 14: 5-9
14. Wagner JG. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokin Biopharm 1976; 4: 443-67
15. Anderson BJ, Meakin GH. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth 2002; 12: 205
16. Díaz SM, Rodarte A, Foley J, Capparelli EV. Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: preliminary study. Pediatr Crit Care Med 2007; 8: 419-24
17. Petroz GC, Sikich N, van Dyk H, Shafer SL, Schily M, Lerman J. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006; 105: 1098-110
18. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 813-20
19. Talke P, Richardson CA, Scheinin M, Fischer DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997; 85: 1136-42
20. Khan Z, Munday IT, Jones RM, Thornton C, Mant TG, Amin D. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999; 83: 372-80